ARCADIA BIOSCIENCES INC (RKDA)

US0390143032 - Common Stock

1.955  -0.03 (-1.76%)

Full estimates are only available for subscribed users, you can see which data is available below.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025
Revenue
YoY % growth
6.78M
-15.57%		9.96M
46.90%		5.33M
-46.49%		6.35M
19.14%
EBITDA
YoY % growth
-23.04M
-39.13%		-16.36M
28.99%		-13.134M
19.72%		-8.67M
33.99%
EBIT
YoY % growth
-24.09M
-39.90%		-16.84M
30.10%		-13.421M
20.30%		-11.302M
15.79%
Operating Margin
-355.31%-169.08%-251.80%-177.98%
EPS
YoY % growth
-11.42
-2,382.61%		-27.09
-137.22%		-17.47
35.51%		-5.73
67.22%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q1 / 24 Q2 / 24 Q3 / 24 Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-2.26
79.20%
Revenue
Q2Q % growth		1.217M
-19.40%
EBITDA
Q2Q % growth		-2.592M
EBIT
Q2Q % growth		-3.168M
21.77%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 -2.52
59.94%		-2.640.124.43%
Q3 2023
Q2Q % growth		 -1.44
70.00%		-3.251.8155.74%
Q2 2023
Q2Q % growth		 -2.65
66.88%		-4.902.2545.87%
Q1 2023
Q2Q % growth		 -10.86
-35.75%		-6.99-3.87-55.43%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q4 2023
Q2Q % growth		 1.17M
17.00%		1.785M-615K-34.45%
Q3 2023
Q2Q % growth		 1.6M
1.91%		1.576M24K1.52%
Q2 2023
Q2Q % growth		 1.05M
-44.15%		1.856M-806K-43.43%
Q1 2023
Q2Q % growth		 1.51M
-53.11%		1.425M85K5.96%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS3.28% 3.28% 2.26% 2.26%
Revenue-33.71% -33.71% -24.54% -24.54%